Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation.

Mazza G, Rombouts K, Rennie Hall A, Urbani L, Vinh Luong T, Al-Akkad W, Longato L, Brown D, Maghsoudlou P, Dhillon AP, Fuller B, Davidson B, Moore K, Dhar D, De Coppi P, Malago M, Pinzani M. · 2015

Read Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. by Mazza G, Rombouts K, Rennie Hall A, Urbani L, Vinh Luong T, Al-Akkad W, Longato L, Brown D, Maghsoudlou P, Dhillon AP, Fuller B, Davidson B, Moore K, Dhar D, De Coppi P, Malago M, Pinzani M. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4528226.txt.

Introduction

Giuseppe Mazza leads a twelve-author team stripping human livers down to their scaffolding, in Scientific Reports in 2015. A liver works only when its cells sit inside the liver's own support matrix. The team washed whole human livers and lobes until the cells were gone, leaving the extracellular matrix, the protein frame, with its shape and vessel paths preserved.

Cubes of that scaffold were reseeded with three human liver cell types and kept for up to 21 days. The cells lived, moved, multiplied, and remodeled their new home. Scaffold cubes placed in mice drew no foreign-body attack, showing the material is tolerated. The work is presented as a key step toward lab-grown livers for transplant, at a time when deaths from liver disease are rising.

Catalog record

CREATORMazza G, Rombouts K, Rennie Hall A, Urbani L, Vinh Luong T, Al-Akkad W, Longato L, Brown D, Maghsoudlou P, Dhillon AP, Fuller B, Davidson B, Moore K, Dhar D, De Coppi P, Malago M, Pinzani M.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4528226

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation By Giuseppe Mazza, Krista Rombouts, Andrew Rennie Hall, Luca Urbani, Tu Vinh Luong, Walid Al-Akkad, Lisa Longato, David Brown, Panagiotis Maghsoudlou, Amar P Dhillon, Barry Fuller, Brian Davidson Published in: Scientific Reports DOI: 10.1038/srep13079 ABSTRACT Abstract Liver synthetic and metabolic function can only be optimised by the growth of cells within a supportive liver matrix. This can be achieved by the utilisation of decellularised human liver tissue. Here we demonstrate complete decellularization of whole human liver and lobes to form an extracellular matrix scaffold with a preserved architecture. Decellularized human liver cubic scaffolds were repopulated for up to 21 days using human cell lines hepatic stellate cells (LX2), hepatocellular carcinoma (Sk-Hep-1) and hepatoblastoma (HepG2), with excellent viability, motility and proliferation and remodelling of the extracellular matrix. Biocompatibility was demonstrated by either omental or subcutaneous xenotransplantation of liver scaffold cubes (5 × 5 × 5 mm) into immune competent mice resulting in absent foreign body responses. We demonstrate decellularization of human liver and repopulation with derived human liver cells. This is a key advance in bioartificial liver development. Deaths from liver disease are increasing worldwide. According to the World Health Organisation, the total deaths caused by cirrhosis and liver cancer have increased by 50 million/year since 19901. In the UK, the number of deaths from cirrhosis in those <65 years have increased ~6 fold in the last 30 years2. At present, liver transplantation is the only successful treatment for patients with end stage liver disease. However, 20% of patients die on the waiting list due to a shortage of organ donors3. To expand the supply of livers available for transplantation, transplant surgeons and physicians have explored several new approaches including split liver transplants, living-related partial donor procedures4 and the increasing use of “marginal” organs such as older donors, steatotic livers, non-heart-beating donors, donors with viral hepatitis, and donors with non-metastatic malignancy5. Despite these medical and surgical developments, it is unlikely that the availability of good liver grafts will ever be sufficient to meet the increasing demand of patients with end stage liver disease. Alternatives to liver transplantation such as liver support systems, including bioartificial livers, and hepatocyte transplantation have been extensively explored but none adopted in clinical practice6,7,8,9,10,11. In the UK, over 40% of the livers offered for transplantation are declined because of prolonged ischemic time or co-morbidities judged beyond marginal criteria12. This provides us with a major opportunity to explore alternative uses of human livers found to be unsuitable for transplantation following organ retrieval. In particular, while cellular viability is easily compromised, extracellular matrix (ECM) is better maintained in the discarded livers and it may be used as scaffold in which to grow normal human liver cells and recreate functional human liver tissue in vitro. Such cells could be obtained from recipient’s hepatocytes obtained from induced pluripotent stem (iPS) cells and thus avoid the need for immunosuppression. Alternatively, liver cells could be obtained from human livers unsuitable for liver transplantation or following liver resection. If successful, ECM liver bioengineering has the potential to be used not only as an alternative to whole organ transplantation but also for toxicity testing during preclinical drug development13 and for more stringent liver disease modelling. Several studies have reported the decellularization of liver tissue obtained from animals14,15,16,17. The resulting 3-dimensional ECM scaffolds have been shown to provide an excellent environment for the in vitro growth of multiple liver cell types retaining excellent functionality18,19. Notably, in 2010, the repopulation of an acellular rat liver scaffold with 50 million mature rat hepatocytes was achieved by cell perfusion via the portal vein. Importantly, hepatocytes migrated beyond the matrix barrier to reach the decellularized sinusoidal spaces20. In 2012, a further step onward was made with the repopulation of a pig liver scaffold with human foetal hepatocytes and stem cells21. However, the decellularization and repopulation of a human liver ECM scaffold with human derived liver cells has not been reported. The aim of this study was firstly to demonstrate the feasibility of an innovative protocol for the decellularization of a single lobe or of the whole human liver and to fully assess the quality and the in vivo biocompatibility of the resulting liver ECM scaffold. Secondly, to assess the capability of different types of human liver cells to repopulate hepatic ECM scaffolds (Fig. 1). Altogether the results of this study provide clear proof of concept data supporting the development of a bio-artificial liver tissue by employing decellularized human ECM liver scaffolds, thus opening, in general, more new possibilities in regenerative medicine for the use of donor human livers currently unsuitable for transplantation. [Figure: Schematic study plan.Human liver unsuitable for transplantation is surgically processed in order to obtain an isolated left lobe or is used as a whole (a,b). Lobes or whole organs are cannulated and decellularized by retrograde perfusion (c). Once decellularization is completed, human liver scaffolds are dissected by scalpel cleavage to obtain liver cubes (d) as a 3D-platform for biocompatibility and bioengineering studies (e,f).] RESULTS Decellularization of human segmental lobes or whole liver Decellularization of the left lobe of the liver (segments 1-2-3) was completed within 14 days of perfusion, and within 6 weeks for the whole human liver (Fig. 2a–c). During and following decellularization the whole liver or lobes gradually became increasingly translucent with the dissolution of cells (Fig. 2a–c). The decellularization protocol, based on a retrograde perfusion through the hepatic venous system and inferior vena cava, was characterized by the combination of five different Cell-Damaging Factors (5CDFs): i) mechanical cell damaging (freezing/thawing) to favor cell destruction; ii) isotonic stress to allow cell lysis; iii) enzymes to allow cell detachment; iv) action of detergents to remove debris; and v) flow shear stress to allow the penetration into the hepatic sinusoid leading to the detachment of cells and debris. Histological evaluation by H&E staining showed no evidence of cell bodies or cellular material including nuclei in the decellularized liver (Fig. 2d). In addition, the general liver tissue architecture appeared fully preserved as shown by Sirius Red staining for collagens (Fig. 2e) and Von Gieson staining for elastin (Fig. 2f). [Figure: Perfusion-decellularization of human liver.Macroscopic appearance of a decellularized left lobe showing preservation of the vascular tree (a), translucent color (b) and a complete human liver (c). Histological comparison (10X and 40X magnification, left panel and right panel, respectively) of fresh liver (FL) and decellularized liver (DL) by Hematoxylin and Eosin (H&E) (d), Sirius Red (SR) (e) and Elastin Von Gieson EVG (f) staining demonstrating removal of cells and preservation of collagen and elastin in DL. Scale bar for 10X magnification: 200 μm and 40X: 50 μm. DNA quantification demonstrated significant DNA reduction from 1425.23 ± 261.37 ng/mg in FL to 47.91 ± 5.82 ng/mg in DL (g). Collagen significantly increased from 5.860726 ± 1.417547 μg/mg in FL to 90.85345 ± 14.16523 μg/mg in DL scaffolds (h). Elastin quantification demonstrated a significant decrease from 34.56827 ± 5.102387 μg/mg to 7.073619 ± 0.434233 μg/mg in in DL scaffolds (i).] The absence of cells in the ECM scaffold was confirmed by the absence of DNA material quantified by DNeasy Blood and Tissue kit (Fig. 2g). As already reported in

Read the complete text